p85α is a microRNA target and affects chemosensitivity in pancreatic cancer

Paul A Toste1, Luyi Li1, Brian E Kadera1

  • 1Department of Surgery, Division of General Surgery, David Geffen School of Medicine at University of California Los Angeles (UCLA), Los Angeles, CA, USA.

Abstract

Insights

Increased phosphoinositide 3-kinase (PI3K) p85α expression enhances pancreatic cancer sensitivity to chemotherapy. MicroRNA-21 directly regulates p85α, influencing PI3K-AKT signaling and potentially improving patient survival.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Pancreatic ductal adenocarcinoma (PDAC) survival is correlated with phosphoinositide 3-kinase (PI3K) regulatory subunit p85α expression.
  • Understanding p85α's role in chemotherapy response and its regulation is crucial for PDAC treatment.

Purpose of the Study:

  • To investigate the impact of p85α expression on pancreatic cancer response to chemotherapy.
  • To elucidate the regulatory role of microRNA-21 (miR-21) in controlling p85α levels.

Main Methods:

  • Generated PDAC cells overexpressing p85α for gemcitabine sensitivity testing (MTT assay).
  • Utilized immunohistochemistry and in situ hybridization to analyze p85α and miR-21 expression in human PDAC tumors.
  • Performed Western blot and luciferase reporter assays to confirm miR-21's direct regulation of p85α and its effect on PI3K-AKT signaling.

Main Results:

  • Higher p85α expression significantly increased sensitivity to gemcitabine, correlating with reduced PI3K-AKT activation.
  • A significant inverse correlation was observed between miR-21 and p85α expression in human PDAC tumors.
  • In vitro, miR-21 overexpression decreased p85α levels and increased AKT phosphorylation, confirmed by luciferase assays.

Conclusions:

  • p85α expression is a key determinant of chemosensitivity in pancreatic ductal adenocarcinoma.
  • MicroRNA-21 directly regulates p85α, thereby influencing PI3K-AKT signaling pathways.
  • These findings offer insights into the mechanisms linking elevated p85α expression to improved PDAC patient survival.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.3K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.8K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K